Symptom control in patients with hay fever in UK general practice: How well are we doing and is there a need for allergen immunotherapy?

Clinical and Experimental Allergy

Volumn 28, Issue 3, 1998, Pages 266-270

  White, P ^a   Smith, H ^b,c   Baker, N ^b   Davis, W ^a   Frew, A ^b  

^a Nightingale Surgery   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c Aldermoor Health Centre   (United Kingdom)

Author keywords

Antihistamine; Hay fever; Immunotherapy; Rhinitis; Steroid; Symptom control

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; STEROID; TRIAMCINOLONE ACETONIDE;

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ARTICLE; HAY FEVER; HUMAN; IMMUNOTHERAPY; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PATIENT REFERRAL; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RHINITIS; SNEEZING; SYMPTOMATOLOGY; TREATMENT INDICATION;

ADOLESCENT; ADULT; FEMALE; HEALTH CARE SURVEYS; HISTAMINE H1 ANTAGONISTS; HUMANS; IMMUNOTHERAPY; MALE; MIDDLE AGED; PATIENT COMPLIANCE; QUESTIONNAIRES; RHINITIS, ALLERGIC, SEASONAL; STEROIDS;

EID: 0031881281     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.1998.00237.x     Document Type: Article

References (12)

1. Office of National Statistics, cited in Lung Asthma Information Agency factsheet; 96/:3. Dept of Public Health Sciences. St Georges Hospital Medical School, London.
2. Burr ML, Butland BK, King S, Vaughan Williams E. Changes in asthma prevalence: two surveys fifteen years apart. Arch Dis Child 1989; 96:1452-6.
3. Ninan TK, Russell G. Respiratory symptoms and atopy in Aberdeen school children: evidence from two surveys. Br Med J 1992; 304:873-5.
4. Britton J. Asthma's changing prevalence. Establishing the true figures is difficult. Br Med J 1992; 304:857-8.
5. Parikh A, Scadding GK. Seasonal allergic rhinitis. Br Med J 1997; 314:1392-5.
6. Committee on the Safety of Medicines. CSM Update: Desensitising vaccines. Br Med J 1986; 293:948.
7. British Society for Allergy and Clinical Immunology Working Party. Allergen immunotherapy for seasonal and perennial allergic rhinitis. Clin Exp Allergy 1993; 23 (S3):3-6.
8. Varney VA, Gaga M, Frew AJ, Aber VR, Kay AB, Durham SR. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergenic drugs. Br Med J 1991; 302:265-9.
9. Bousquet J, Bullinger M, Fayol C et al. Assessment of quality of life in patients with perennial rhinitis with the French version of the SF-36 questionnaire. J Allergy Clin Immunol 1994; 94:182-8.
10. Bousquet J, Knani J, Dhivert H, Richard A et al. Quality of life in asthma. 1. Internal consistency and validity of the SF-36 health status questionnaire. Am J Respir Crit Care Med 1994; 149:371-5.
11. Wise J. Hay fever drug to become prescription only. Br Med J 1997; 314:1299.
12. Passalacqua G, Bousquet J, Bachert C, Church MK et al. The clinical safety of H1-receptor antagonists. An EAACI position paper. Allergy 1996; 51:666-75.